Foot health and quality of life in women with breast cancer undergoing chemotherapy: a cross-sectional study.
Chemotherapy is one of the most widely used therapies for breast cancer, triggering important...
Read MoreAug 21, 2023
Chemotherapy is one of the most widely used therapies for breast cancer, triggering important...
Read MoreAug 21, 2023
Our Institution instituted curriculum reform in 2013. We sought to examine the impact of rotation...
Read MoreAug 14, 2023
Current trends in surgical neuro-oncology show that early discharges are safe and feasible with...
Read MoreAug 14, 2023
To investigate the effect and the mechanism of gene deletion on the drug susceptibility of...
Read MoreAug 14, 2023
Neonatal Opioid Withdrawal Syndrome (NOWS) is a condition that often occurs in neonates born to...
Read MoreAug 14, 2023
In this study, we aimed to evaluate the perinatal outcomes of dichorionic diamniotic (DCDA) twin...
Read MoreAug 14, 2023
Multimodal treatment, including assisted reproductive technology, is necessary in young patients...
Read MoreAug 14, 2023
Japan’s health insurance covers multigene panel testing. This study aimed to determine the...
Read MoreAug 14, 2023
Anti-Müllerian hormone (AMH) has recently emerged as a promising biomarker for the detection of...
Read MoreAug 14, 2023
Deaths from metastatic breast cancer continue to be a leading cause of global cancer mortality...
Read MoreAug 7, 2023
Acute lower uncomplicated urinary tract infection (uUTI) affects a large proportion of women....
Read MoreAug 7, 2023
Folic acid (FA) supplementation is associated with a lower risk of the neural tube and heart...
Read MoreAug 7, 2023
In patients with advanced ovarian cancer, the modelled CA-125 ELIMination rate constant K (KELIM)...
Read MoreAug 7, 2023
Breast cancer, ovarian cancer, and uterus cancer are among the most common female cancers. They...
Read MoreAug 7, 2023
Breast density is strongly associated with breast cancer risk. Fully automated quantitative...
Read MoreAug 7, 2023
Cisgender women account for one of every five new U.S. HIV diagnoses, with the majority (86%)...
Read MoreJul 31, 2023
To report long-term oncologic and functional outcomes of a large consecutive single center series...
Read MoreJul 31, 2023
BRCA1/2 germline mutations are the most well-known genetic determinants for breast cancer....
Read MoreJul 31, 2023
We examined the blood concentrations of carbohydrate antigen 125- Thomsen-nouveau (CA125-Tn) and...
Read MoreJul 31, 2023
To apply the Van Nuys Prognostic Index (VNPI) and the Memorial Sloan Kettering Cancer Center...
Read More